Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural phenomenon.

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The Washington Post reports.

Republicans lambasted Democrats last year for subsidizing monthly payments that seniors pay for prescription drug insurance, but the Trump administration is continuing the policy, it told insurers Monday.